Status:
COMPLETED
Electromyographic Calibration Guided by Depth of Anesthesia
Lead Sponsor:
University Hospital Ulm
Collaborating Sponsors:
Technical University of Munich
Conditions:
Neuromuscular Blockade
Eligibility:
All Genders
18+ years
Brief Summary
The goal of the CELESTE study is to evaluate whether calibration of EMG is needed for reliable interpretation of neuromuscular function and if so, to identify the minimal necessary depth of anesthesia...
Detailed Description
Neuromuscular monitoring is used to document neuromuscular function intra-operatively. Failure to restore neuromuscular function prior to extubation results in residual neuromuscular blockade which is...
Eligibility Criteria
Inclusion
- signed informed written consent
- BMI 17.5-30 kg/m\^2
- ASA \<= 3
- supine positioning during surgery with intraoperative access to both arms
- absence of allergy to muscle relaxants and reversal agents
- absence of neuromuscular disease
Exclusion
- ambulatory patients for whom discharge is planned within 12 hours of anaesthesia
- patients undergoing minor surgical
- procedures scheduled outside the operating room
- patients who are endotracheally intubated prior to surgery
- pregnancy
- indication for rapid sequence induction
- patients undergoing arm surgery
- patients with preceding injuries impairing muscle or nerve function of the arm (e.g., finger amputation)
Key Trial Info
Start Date :
January 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04911088
Start Date
January 16 2022
End Date
May 31 2023
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ulm
Ulm, Baden-Wurttemberg, Germany, 89073